Target intelligence / Profile preview

Promoter-associated ncRNA regulator of CCND1 (PNCRNA-D)

Target
PNCRNA-D
Molecular classification
Long noncoding RNA (lncRNA), Non-coding RNA
01

Overview

The **promoter-associated ncRNA regulator of CCND1 (PNCRNA-D)**, also known as **pncRNA-D**, is a 602-nucleotide long noncoding RNA (lncRNA) transcribed from the promoter region of the human cyclin D1 (CCND1) gene[1][2][3][7][9]. It does not encode a protein but functions by interacting with the RNA-binding protein TLS/FUS. This interaction leads to TLS/FUS inhibiting the histone acetyltransferase activity of CBP/p300 at the CCND1 promoter, thereby repressing CCND1 transcription[1][7]. PNCRNA-D expression is upregulated by cellular stresses like irradiation or osmotic shock, and its regulatory activity is modulated through N6-methyladenosine (m^6^A) RNA modification. Reduced m^6^A methylation of PNCRNA-D under stress conditions increases its interaction with TLS/FUS, leading to greater suppression of cyclin D1 and cell cycle arrest at G0/G1 phase[1][2]. PNCRNA-D is a key regulator of cell proliferation and likely plays a role in tumor suppression; it is not currently a recognized therapeutic target or associated with any drugs or clinical biomarkers[1][2][7].

Other names
pncRNA-Dpromoter-associated ncRNApromoter-associated noncoding RNA from the CCND1 promoter
02

Biological functions

Regulation of CCND1 (cyclin D1) gene expressionCell cycle control, especially G1/S phase checkpointModulation of proliferation (cell growth inhibition)Chromatin/transcriptional regulation (recruiting RNA-binding protein TLS/FUS and inhibiting histone acetyltransferase activity at CCND1 promoter)
03

Disease associations

Cancer (through regulation of cyclin D1, a known cancer-associated cell cycle gene)

Beyond the preview

Go deeper on Promoter-associated ncRNA regulator of CCND1 (PNCRNA-D).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Promoter-associated ncRNA regulator of CCND1 (PNCRNA-D).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call